Evidence map›Paper›PMID 42421687›Full record

ArticleFrontiers in oncology2026

TRPV1-mediated calcium signaling underlies the synergistic pro-apoptotic effects of lidocaine and melatonin in SH-SY5Y neuroblastoma cells.

Ebru Aladag, Ishak Suat Ovey

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ebru AladagDepartment of Anesthesiology and Reanimation, Faculty of Medicine, Alanya Alaaddin Keykubat University, Alanya, Türkiye.
Ishak Suat OveyDepartment of Physiology, Faculty of Medicine, Alanya Alaaddin Keykubat University, Alanya, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lidocaine, an amide-type local anesthetic, and melatonin, a multifunctional indoleamine with mitochondrial regulatory and anticancer properties, have each been reported to modulate cancer cell survival. However, whether these agents cooperatively promote apoptosis in neuroblastoma cells through transient receptor potential vanilloid 1 (TRPV1)-mediated calcium signaling remains insufficiently defined. This study investigated the individual and combined effects of lidocaine and melatonin on SH-SY5Y human neuroblastoma cells, focusing on TRPV1-dependent intracellular mechanisms. Intracellular Ca²

Indexed as

apoptosiscalcium signalinglidocainemelatoninmitochondrial dysfunctionneuroblastomaoxidative stressTRPV1 channel

Identifiers

PMID42421687
PMCPMC13341917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.